To test the potential role of ISG15 in activating the adaptive arm of the immune system, we assessed MHC class I surface expression, a marker for efficient antigen presentation, on T47D breast cancer cells devoid of free ISG15 expression and IFNβ-treated T47D cells expressing high levels of ISG15. Here, IFNB1 is linked to breast cancer.